Norinchukin Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.2M | Buy |
25,049
+846
| +3% | +$394K | 0.13% | 103 |
|
|
2025
Q4 | $11M | Buy |
24,203
+2,177
| +10% | +$938K | 0.13% | 108 |
|
|
2025
Q3 | $8.63M | Buy |
22,026
+90
| +0.4% | +$37.6K | 0.12% | 117 |
|
|
2025
Q2 | $9.77M | Buy |
21,936
+1,859
| +9% | +$857K | 0.15% | 103 |
|
|
2025
Q1 | $9.73M | Buy |
20,077
+6,120
| +44% | +$2.85M | 0.18% | 90 |
|
|
2024
Q4 | $5.62M | Buy |
13,957
+1,106
| +9% | +$513K | 0.12% | 109 |
|
|
2024
Q3 | $5.98M | Buy |
12,851
+1,716
| +15% | +$824K | 0.14% | 96 |
|
|
2024
Q2 | $5.22M | Buy |
11,135
+5
| +0% | +$2.17K | 0.15% | 89 |
|
|
2024
Q1 | $4.65M | Sell |
11,130
-237
| -2% | -$100K | 0.14% | 95 |
|
|
2023
Q4 | $4.63M | Sell |
11,367
-1,659
| -13% | -$613K | 0.11% | 93 |
|
|
2023
Q3 | $4.53M | Sell |
13,026
-13,803
| -51% | -$4.83M | 0.11% | 104 |
|
|
2023
Q2 | $9.44M | Buy |
26,829
+6,622
| +33% | +$2.23M | 0.16% | 103 |
|
|
2023
Q1 | $6.37M | Buy |
20,207
+522
| +3% | +$157K | 0.13% | 110 |
|
|
2022
Q4 | $5.68M | Sell |
19,685
-4,391
| -18% | -$1.34M | 0.12% | 117 |
|
|
2022
Q3 | $6.97M | Buy |
24,076
+2,438
| +11% | +$701K | 0.14% | 105 |
|
|
2022
Q2 | $6.1M | Sell |
21,638
-4,719
| -18% | -$1.26M | 0.12% | 113 |
|
|
2022
Q1 | $6.88M | Buy |
26,357
+2,482
| +10% | +$589K | 0.09% | 131 |
|
|
2021
Q4 | $5.24M | Sell |
23,875
-1,919
| -7% | -$373K | 0.07% | 154 |
|
|
2021
Q3 | $4.68M | Buy |
25,794
+1,399
| +6% | +$273K | 0.07% | 160 |
|
|
2021
Q2 | $4.92M | Buy |
24,395
+217
| +0.9% | +$45.4K | 0.07% | 143 |
|
|
2021
Q1 | $5.2M | Buy |
24,178
+1,135
| +5% | +$249K | 0.07% | 133 |
|
|
2020
Q4 | $5.45M | Sell |
23,043
-132
| -0.6% | -$30.3K | 0.08% | 123 |
|
|
2020
Q3 | $6.31M | Buy |
23,175
+778
| +3% | +$215K | 0.1% | 102 |
|
|
2020
Q2 | $6.5M | Buy |
22,397
+9
| +0% | +$2.44K | 0.11% | 97 |
|
|
2020
Q1 | $5.33M | Sell |
22,388
-12,421
| -36% | -$2.85M | 0.1% | 100 |
|
|
2019
Q4 | $7.62M | Sell |
34,809
-3,008
| -8% | -$609K | 0.1% | 126 |
|
|
2019
Q3 | $6.41M | Buy |
37,817
+1,004
| +3% | +$178K | 0.09% | 146 |
|
|
2019
Q2 | $6.75M | Sell |
36,813
-12,442
| -25% | -$2.18M | 0.1% | 128 |
|
|
2019
Q1 | $9.06M | Buy |
49,255
+1,726
| +4% | +$319K | 0.12% | 129 |
|
|
2018
Q4 | $7.88M | Buy |
47,529
+14,658
| +45% | +$2.54M | 0.11% | 130 |
|
|
2018
Q3 | $6.34M | Buy |
32,871
+3,998
| +14% | +$712K | 0.09% | 136 |
|
|
2018
Q2 | $4.91M | Buy |
28,873
+5,608
| +24% | +$869K | 0.07% | 142 |
|
|
2018
Q1 | $3.79M | Buy |
23,265
+3,046
| +15% | +$498K | 0.06% | 148 |
|
|
2017
Q4 | $3.03M | Buy |
20,219
+1,454
| +8% | +$215K | 0.05% | 169 |
|
|
2017
Q3 | $2.85M | Buy |
18,765
+1,481
| +9% | +$223K | 0.06% | 186 |
|
|
2017
Q2 | $2.23M | Buy |
17,284
+1,140
| +7% | +$137K | 0.05% | 228 |
|
|
2017
Q1 | $1.76M | Buy |
16,144
+1,097
| +7% | +$96.6K | 0.04% | 254 |
|
|
2016
Q4 | $1.11M | Buy |
15,047
+1,781
| +13% | +$145K | 0.03% | 308 |
|
|
2016
Q3 | $1.16M | Buy |
13,266
+292
| +2% | +$27.6K | 0.03% | 293 |
|
|
2016
Q2 | $1.12M | Buy |
12,974
+329
| +3% | +$28.4K | 0.03% | 281 |
|
|
2016
Q1 | $1M | Buy |
12,645
+1,166
| +10% | +$105K | 0.02% | 299 |
|
|
2015
Q4 | $1.44M | Sell |
11,479
-2,516
| -18% | -$304K | 0.04% | 246 |
|
|
2015
Q3 | $1.46M | Buy |
13,995
+195
| +1% | +$25.1K | 0.04% | 252 |
|
|
2015
Q2 | $1.7M | Sell |
13,800
-553
| -4% | -$69.7K | 0.04% | 248 |
|
|
2015
Q1 | $1.69M | Buy |
14,353
+180
| +1% | +$21.6K | 0.04% | 246 |
|
|
2014
Q4 | $1.68M | Buy |
14,173
+4,614
| +48% | +$520K | 0.04% | 232 |
|
|
2014
Q3 | $1.07M | Buy |
9,559
+746
| +8% | +$71K | 0.03% | 205 |
|
|
2014
Q2 | $834K | Sell |
8,813
-943
| -10% | -$66.1K | 0.02% | 220 |
|
|
2014
Q1 | $690K | Buy |
9,756
+1,024
| +12% | +$81.1K | 0.02% | 256 |
|
|
2013
Q4 | $649K | Sell |
8,732
-12
| -0.1% | -$836 | 0.02% | 245 |
|
|
2013
Q3 | $663K | Buy |
+8,744
| New | +$696K | 0.02% | 231 |
|
Other funds holding VRTX
VCM
VPM
Norinchukin Bank's VRTX Position: Q1 2026 in Review
Norinchukin Bank increased its Vertex Pharmaceuticals (VRTX) stake by 3.5% in Q1 2026, buying an estimated $394K and bringing the position to 25,049 shares worth $11.2M. The position accounts for 0.13% of the portfolio, ranked #103.
Norinchukin Bank first reported a position in VRTX in Q3 2013 and has held it in 51 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Norinchukin Bank held 25,049 shares of Vertex Pharmaceuticals worth $11.2M as of Q1 2026.
- Norinchukin Bank bought 846 Vertex Pharmaceuticals shares in Q1 2026, an estimated $394K.
- Vertex Pharmaceuticals made up 0.13% of Norinchukin Bank's portfolio in Q1 2026, its #103 holding.
- Norinchukin Bank first reported a position in Vertex Pharmaceuticals in Q3 2013 and has held it in 51 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Norinchukin Bank's 13F filing for Q1 2026, filed 15 May 2026.